178 related articles for article (PubMed ID: 18420147)
1. Separate entrance and exit portals for ligand traffic in Mycobacterium tuberculosis FabH.
Sachdeva S; Musayev FN; Alhamadsheh MM; Scarsdale JN; Wright HT; Reynolds KA
Chem Biol; 2008 Apr; 15(4):402-12. PubMed ID: 18420147
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A.
Musayev F; Sachdeva S; Scarsdale JN; Reynolds KA; Wright HT
J Mol Biol; 2005 Mar; 346(5):1313-21. PubMed ID: 15713483
[TBL] [Abstract][Full Text] [Related]
3. The tail of mycolic acids.
Lu JZ; Prigge ST
Chem Biol; 2008 Apr; 15(4):309-10. PubMed ID: 18420136
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III.
Scarsdale JN; Kazanina G; He X; Reynolds KA; Wright HT
J Biol Chem; 2001 Jun; 276(23):20516-22. PubMed ID: 11278743
[TBL] [Abstract][Full Text] [Related]
5. Probing the mechanism of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III mtFabH: factors influencing catalysis and substrate specificity.
Brown AK; Sridharan S; Kremer L; Lindenberg S; Dover LG; Sacchettini JC; Besra GS
J Biol Chem; 2005 Sep; 280(37):32539-47. PubMed ID: 16040614
[TBL] [Abstract][Full Text] [Related]
6. The Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue.
Veyron-Churlet R; Molle V; Taylor RC; Brown AK; Besra GS; Zanella-Cléon I; Fütterer K; Kremer L
J Biol Chem; 2009 Mar; 284(10):6414-24. PubMed ID: 19074144
[TBL] [Abstract][Full Text] [Related]
7. Identification and substrate specificity of beta -ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis.
Choi KH; Kremer L; Besra GS; Rock CO
J Biol Chem; 2000 Sep; 275(36):28201-7. PubMed ID: 10840036
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase III (mtFabH) assay: principles and method.
Sachdeva S; Reynolds KA
Methods Mol Med; 2008; 142():205-13. PubMed ID: 18437316
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of bacterial FabH suggest a molecular basis for the substrate specificity of the enzyme.
Gajiwala KS; Margosiak S; Lu J; Cortez J; Su Y; Nie Z; Appelt K
FEBS Lett; 2009 Sep; 583(17):2939-46. PubMed ID: 19665020
[TBL] [Abstract][Full Text] [Related]
10. Probing reactivity and substrate specificity of both subunits of the dimeric Mycobacterium tuberculosis FabH using alkyl-CoA disulfide inhibitors and acyl-CoA substrates.
Sachdeva S; Musayev F; Alhamadsheh MM; Neel Scarsdale J; Tonie Wright H; Reynolds KA
Bioorg Chem; 2008 Apr; 36(2):85-90. PubMed ID: 18096200
[TBL] [Abstract][Full Text] [Related]
11. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
[TBL] [Abstract][Full Text] [Related]
12. Alkyl-CoA disulfides as inhibitors and mechanistic probes for FabH enzymes.
Alhamadsheh MM; Musayev F; Komissarov AA; Sachdeva S; Wright HT; Scarsdale N; Florova G; Reynolds KA
Chem Biol; 2007 May; 14(5):513-24. PubMed ID: 17524982
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthesis. Role of active site histidines and lysine in Cys-His-His-type beta-ketoacyl-acyl carrier protein synthases.
von Wettstein-Knowles P; Olsen JG; McGuire KA; Henriksen A
FEBS J; 2006 Feb; 273(4):695-710. PubMed ID: 16441657
[TBL] [Abstract][Full Text] [Related]
14. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions.
Veyron-Churlet R; Bigot S; Guerrini O; Verdoux S; Malaga W; Daffé M; Zerbib D
J Mol Biol; 2005 Nov; 353(4):847-58. PubMed ID: 16213523
[TBL] [Abstract][Full Text] [Related]
15. X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB).
Sridharan S; Wang L; Brown AK; Dover LG; Kremer L; Besra GS; Sacchettini JC
J Mol Biol; 2007 Feb; 366(2):469-80. PubMed ID: 17174327
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
[TBL] [Abstract][Full Text] [Related]
17. PqsBC, a Condensing Enzyme in the Biosynthesis of the Pseudomonas aeruginosa Quinolone Signal: CRYSTAL STRUCTURE, INHIBITION, AND REACTION MECHANISM.
Drees SL; Li C; Prasetya F; Saleem M; Dreveny I; Williams P; Hennecke U; Emsley J; Fetzner S
J Biol Chem; 2016 Mar; 291(13):6610-24. PubMed ID: 26811339
[TBL] [Abstract][Full Text] [Related]
18. The catalysis of the 1,1-proton transfer by alpha-methyl-acyl-CoA racemase is coupled to a movement of the fatty acyl moiety over a hydrophobic, methionine-rich surface.
Bhaumik P; Schmitz W; Hassinen A; Hiltunen JK; Conzelmann E; Wierenga RK
J Mol Biol; 2007 Apr; 367(4):1145-61. PubMed ID: 17320106
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure and substrate specificity of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
Qiu X; Choudhry AE; Janson CA; Grooms M; Daines RA; Lonsdale JT; Khandekar SS
Protein Sci; 2005 Aug; 14(8):2087-94. PubMed ID: 15987898
[TBL] [Abstract][Full Text] [Related]
20. 3D-QSAR, molecular docking studies, and binding mode prediction of thiolactomycin analogs as mtFabH inhibitors.
Lu X; Chen Y; You Q
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):240-9. PubMed ID: 19968566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
